Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis

Summary

Purpose of this study is to determine the safety and efficacy of topical applications of NB-001 as compared to placebo for the treatment of recurrent herpes labialis.

Conditions

• Herpes Labialis

Interventions

DRUG

NB-001

Sponsors & Collaborators

• NanoBio Corporation

  lead INDUSTRY

Principal Investigators

• William Abramovits, MD · Dermatology Treatment and Research Center

• Jeffrey Adelglass, MD · Research Across America

• Maurice Archuleta, MD · Front Range Clinical Research

• Brian Bock, DO · Bock Clinical Research Incorporated

• Alicia Bucko, DO · Academic Dermatology Associates

• Teresa Coats, MD · Benchmark Research

• Lisa Cohen, DO · Suncoast Clinical Research

• John Eck, MD · Advanced Clinical Research Incorporated

• Douglass Forsha, MD · South Valley Dermatology Center

• David Fried, MD · Omega Medical Research

• Helen Henry, MD · Westover Heights Clinic

• Michael T Jarratt, MD · Derm Research Incorporated

• Terry Jones, MD · J & S Studies

• Steven Kaster, MD · Wenatchee Valley Medical Center

• Leon Kircik, MD · DermResearch, PLCC

• Ronica Kluge, MD · Clinical Physiology Associates

• Elias Kolettis, MD · Clinical Research of West Florida

• Oswald Mikell, MD · Okati Research Center, LLC

• Eugene Monroe, MD · Advance Healthcare

• Edward Pornoy, MD · Westlake Medical Research

• Harvey Resnick, MD · R/D Clinical Research Incorporated

• Dennis Riff, MD · Advanced Clinical Research Institute

• Mark A Ringold, MD · New River Valley Research Institute

• Ronald Savin, MD · PC

• Daniel Stewart, MD · MI Center for Skin Care Research

• Cynthia B Strout, MD · Coastal Carolina Research Center

• Wayne Harper, MD · Wake Research Associates, LLM

• Timothy Howard, MD · Medical Affiliated Reseach Center Incorporated

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2007-02-28

Primary Completion

2007-12-31

Completion

2007-12-31

Countries

• United States

Study Locations